Skip to content

Clinical trials

Phase 3 Chlamydia Infections trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Chlamydia Infections Phase: Phase 3 Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20031
20041
20051
20062
20081
20091
20102
20111
20141
20201
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Terminated2
Unknown status2
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Institute of Allergy and Infectious Diseases (NIAID)3
Botswana Harvard AIDS Institute Partnership1
Endo USA Inc., a Keenova Therapeutics Company1
Evofem Inc.1
FHI 3601
Identigene1
Melinta Therapeutics, Inc.1
National Eye Institute (NEI)1
University of Bristol1
University of Pennsylvania1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Chlamydia Infections15
Gonorrhea9
Sexually Transmitted Diseases5
HIV Infections4
Vaginosis, Bacterial3
Herpes Genitalis2
Acquired Immunodeficiency Syndrome1
Arthritis, Reactive1
Infections1
Ophthalmia Neonatorum1

Trials

Showing 76 to 15 of 15. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.